Arlin 400 mg is a potent oxazolidinone-class antibiotic with broad-spectrum activity against Gram-positive aerobic bacteria, some Gram-positive anaerobes, and selected Gram-negative pathogens. It is specifically designed to combat drug-resistant infections, including vancomycin-resistant Enterococcus faecium (VRE) and methicillin-resistant Staphylococcus aureus (MRSA). Arlin acts by inhibiting bacterial protein synthesis at a unique site, making it effective even when other antibiotics fail.
Available in oral and intravenous formulations, Arlin allows flexible dosing depending on the patient’s condition, age, and severity of infection. Its excellent oral bioavailability (~100%) ensures seamless transition from intravenous to oral therapy. Arlin 400 mg is commonly used in hospitals for serious infections where resistant bacteria are suspected or confirmed.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Arlin 400 mg is indicated for the treatment of:
Vancomycin-Resistant Enterococcus faecium (VRE) infections, including concurrent bacteremia
Nosocomial pneumonia caused by Staphylococcus aureus (MSSA & MRSA) or Streptococcus pneumoniae, including multi-drug resistant strains
Complicated skin and soft tissue infections, including diabetic foot infections (without osteomyelitis) caused by S. aureus (MSSA & MRSA), Streptococcus pyogenes, or Streptococcus agalactiae
Uncomplicated skin and soft tissue infections caused by S. aureus (MSSA) or Streptococcus pyogenes
Community-acquired pneumonia caused by Streptococcus pneumoniae, including cases with concurrent bacteremia, or S. aureus (MSSA only)
Oxazolidinone antibiotic (macrolide-like)
Arlin 400 mg selectively inhibits bacterial protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit, preventing the formation of a functional 70S initiation complex, which is essential for bacterial translation.
Key Points:
Bacteriostatic against enterococci and staphylococci
Bactericidal against most streptococcal strains
Effective against multi-drug resistant Gram-positive organisms
Oral formulation bioavailability ~100%
IV infusion administered over 30–120 minutes
Adults & Adolescents (≥12 years):
Complicated skin infections / community-acquired pneumonia: 600 mg IV or oral twice daily, 10–14 days
Nosocomial pneumonia / VRE infections: 600 mg IV or oral twice daily, 14–28 days
Uncomplicated skin infections: 400–600 mg orally twice daily, 10–14 days
Pediatric Patients:
Birth to 11 years: 10 mg/kg IV or oral, dosing t.i.d. or b.i.d depending on age and infection type
Neonates <7 days: 10 mg/kg IV every 12 hours; adjust to every 8 hours if needed
Administration Notes:
Oral suspension: Reconstitute with boiled and cooled water; use within 21 days
IV infusion: Ready-to-use single-use bags; administer over 30–120 minutes; do not mix with other additives
Monoamine oxidase inhibition: Potential interactions with adrenergic and serotonergic agents
Concomitant serotonergic drugs may increase risk of serotonin syndrome
Care with vasopressors, dopamine, epinephrine, or serotonin reuptake inhibitors
Known hypersensitivity to Arlin or components
Use with MAO inhibitors or within 2 weeks of MAO therapy
Uncontrolled hypertension, pheochromocytoma, thyrotoxicosis, or carcinoid syndrome
Caution with agents acting on adrenergic or serotonergic pathways
Common:
Diarrhea, nausea, headache
Other reported effects:
Oral/vaginal candidiasis, hypertension, dyspepsia, localized abdominal pain
Pruritus, tongue discoloration
Rare: convulsions, visual disturbances, serotonin syndrome
Monitor patients for recurrent nausea, vomiting, or unexplained acidosis
Watch for signs of serotonin syndrome with concomitant serotonergic drugs
Ophthalmic evaluation if visual changes occur
Use caution in patients with a history of seizures
Pregnancy Category C: Use only if benefits outweigh risks
Unknown if excreted in human milk; caution advised when nursing
Store at 15–30°C, protected from light and moisture
Keep out of reach of children
Arlin 400 mg inhibits bacterial protein synthesis by preventing formation of the 70S initiation complex. It is bacteriostatic for most enterococci and staphylococci and bactericidal for streptococci. Its unique mechanism makes it effective against resistant Gram-positive pathogens.
Login Or Registerto submit your questions to seller
No none asked to seller yet